Section 12.8 of Q7A says that analytical methods should be validated unless the method
employed is included in the relevant pharmacopoeia or other recognized standard reference.
However, the section clarifies that “the degree of analytical validation performed should reflect the
purpose of the analysis and the stage of the API production process”.
